Tag: Vaccine

Research Lecture – Antibody based HIV Vaccines – are we any closer?

On the 26th November 2013, the Wits Faculty of Health Sciences will host the 9th Prestigious Research Lecture presented by Professor Maria Papathanasopoulos and Dr Penny Moore.

Southern Vaccine Advocacy Challenge

The SVAC will award five grants to support innovative advocacy initiatives around a specific vaccine-related event, issue or policy.

HIV Vaccine development: Challenges and Progress

As we enter the fourth decade of the HIV epidemic, UNAIDS vision calls for zero discrimination, zero new HIV infections and zero AIDS related deaths through universal access to effective HIV prevention, treatment, care and support. Access to antiretroviral therapy provides the potential to curb AIDS related deaths, but there is still a very long way to go. Until fairly recently, most HIV prevention strategies focused on socio-behavioural interventions with condoms, ‘faithful’ relationships and abstinence together being hailed as the main prevention messages. Current strategies include the use of vaginal microbicides and male medical circumcision. Although a lot of progress has been made in the prevention research arena, it is irrefutable that the development of a safe and effective vaccine becomes the best hope for ultimately ending the HIV pandemic. However, the field of HIV vaccine development research is fraught with many extraordinary challenges.

Opinion: Cervical cancer – a vaccine preventable disease

Cervical cancer will develop in one out of every 35 South African women and it is the leading cause of cancer deaths amongst South African women. Approximately nine South African women die every day from cervical cancer. The aim of this opinion piece is to highlight the fact that the cervical screening does not seems to work in South Africa (low coverage) and therefore vaccination against Human Papilloma Virus (HPV), which is causing cervical cancer, should not be postponed anymore, in order to save lives.

HIV vaccine phase II trial commences in South Africa

Research to establish whether a vaccine can slow down progression of disease in HIV positive people has started at the University of Limpopo.

Join PHASA

Be part of our network of leaders and innovators.

Join now